Literature DB >> 18613296

Psychosocial issues in genetic testing for familial adenomatous polyposis: a review of the literature.

K F L Douma1, N K Aaronson, H F A Vasen, E M A Bleiker.   

Abstract

OBJECTIVES: Familial adenomatous polyposis (FAP) is characterized by the development of multiple adenomas in the colon that can lead to colorectal cancer. Being a carrier for FAP is hypothesized to have a negative impact on psychosocial well-being. This paper reviews the current literature on the psychosocial aspects of FAP.
METHODS: Four literature databases were used to identify all papers published between 1986 and 2007 about psychosocial and behavioral issues in FAP related to genetic testing. The following topics were reviewed: uptake and psychosocial impact of genetic testing, endoscopic screening behavior and psychosocial well-being in general.
RESULTS: Seventeen papers were identified. Across studies, genetic test uptake varied between 62 and 97%. Two out of three studies showed clinical levels of anxiety and/or depression after genetic testing. A minority of individuals were not reassured by a negative test result, and intended to continue endoscopic surveillance. Well-being (e.g. quality of life, family functioning) was found to be lower in some studies, while comparable to the general population in other studies. The studies had several shortcomings, such as mixed patient population (e.g. colorectal and breast cancer) and small sample sizes, and provided no information on other potentially important issues, such as psychosexual development.
CONCLUSIONS: Future studies should employ larger sample sizes and standardized measurements. Additionally, future studies should address the long-term consequences of genetic testing for FAP, psychosexual development and consequences of FAP for the family as a whole.

Entities:  

Mesh:

Year:  2008        PMID: 18613296     DOI: 10.1002/pon.1357

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  17 in total

1.  Points to consider in assessing and appraising predictive genetic tests.

Authors:  Wolf H Rogowski; Scott D Grosse; Jürgen John; Helena Kääriäinen; Alastair Kent; Ulf Kristofferson; Jörg Schmidtke
Journal:  J Community Genet       Date:  2010-10-16

Review 2.  Specific psychosocial issues of individuals undergoing genetic counseling for cancer - a literature review.

Authors:  Willem Eijzenga; Daniela E E Hahn; Neil K Aaronson; Irma Kluijt; Eveline M A Bleiker
Journal:  J Genet Couns       Date:  2013-08-31       Impact factor: 2.537

3.  The challenge of developmentally appropriate care: predictive genetic testing in young people for familial adenomatous polyposis.

Authors:  Rony E Duncan; Lynn Gillam; Julian Savulescu; Robert Williamson; John G Rogers; Martin B Delatycki
Journal:  Fam Cancer       Date:  2009-09-17       Impact factor: 2.375

4.  SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.

Authors:  Tania Cruz-Mariño; Yaimeé Vázquez-Mojena; Luis Velázquez-Pérez; Yanetza González-Zaldívar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Annelié Estupiñán-Rodríguez; José Miguel Laffita-Mesa; Luis E Almaguer-Mederos; Milena Paneque
Journal:  J Community Genet       Date:  2015-04-19

5.  Returning individual research results: development of a cancer genetics education and risk communication protocol.

Authors:  J Scott Roberts; David I Shalowitz; Kurt D Christensen; Jessica N Everett; Scott Y H Kim; Leon Raskin; Stephen B Gruber
Journal:  J Empir Res Hum Res Ethics       Date:  2010-09       Impact factor: 1.742

6.  Family matters: examining a multi-family group intervention for women with BRCA mutations in the scope of genetic counselling.

Authors:  Alvaro Mendes; Raquel Chiquelho; Teresa Almeida Santos; Liliana Sousa
Journal:  J Community Genet       Date:  2010-10-05

7.  Parental attitudes, beliefs, and perceptions about genetic testing for FAP and colorectal cancer surveillance in minors.

Authors:  Fallon R Levine; James E Coxworth; David A Stevenson; Thérèse Tuohy; Randall W Burt; Anita Y Kinney
Journal:  J Genet Couns       Date:  2010-03-02       Impact factor: 2.537

8.  Disclosing individual CDKN2A research results to melanoma survivors: interest, impact, and demands on researchers.

Authors:  Kurt D Christensen; J Scott Roberts; David I Shalowitz; Jessica N Everett; Scott Y H Kim; Leon Raskin; Stephen B Gruber
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-02-09       Impact factor: 4.254

9.  The FAP self-concept scale (adult form).

Authors:  Mary Jane Esplen; Noreen Stuckless; Terri Berk; Kate Butler; Steve Gallinger
Journal:  Fam Cancer       Date:  2008-08-13       Impact factor: 2.375

10.  Making the decision to participate in predictive genetic testing for arrhythmogenic right ventricular cardiomyopathy.

Authors:  April Manuel; Fern Brunger
Journal:  J Genet Couns       Date:  2014-07-01       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.